BACKGROUND: Covid-19 vaccination has started in the majority of the countries at the global level. Cancer patients are at high risk for infection, serious illness, and death from COVID-19 and need vaccination guidance and support. Guidance availability in the English language only is a major limit for recommendations' delivery and their application in the world's population and generates information inequalities across the different populations. METHODS: Most of the available COVID-19 vaccination guidance for cancer patients was screened and scrutinized by the European Cancer Patients Coalition (ECPC) and an international oncology panel of 52 physicians from 33 countries. RESULTS: A summary guidance was developed and provided in 28 languages in order to reach more than 70 percent of the global population. CONCLUSION: Language barrier and e-guidance availability in the native language are the most important barriers when communicating with patients. E-guidance availability in various native languages should be considered a major priority by international medical and health organizations that are communicating with patients at the global level.

Acıbadem University Faculty of Medicine Turkey

Advanced Radiation Oncology Department IRCCS Sacro Cuore Don Calabria Negrar Verona University of Brescia Verona Italy

Beatson West of Scotland Cancer Center Strathclyde University Glasgow UK

Cell Biologist CEO Bladder Cancer Oslo Norway

Chairmen of the Board Young Saving Association Turkey

Department Biomedical Sciences and Medicine University of Algarve Faro Portugal

Department for Radiosurgery and SBRT Clinical center of Serbia Belgrade Serbia

Department Medical Oncology Bank of Cyprus Oncology Centre Nicosia Cyprus

Department Medical Oncology Berat Regional Hospital Berat Albania

Department Medical Oncology Center of Excellence Heart and Brain Hospital Pleven Medical University Pleven Bulgaria

Department Medical Oncology Clinica San Carlo Paderno Dugnano Milano Italy

Department Medical Oncology Escola Paulista de Medicina Federal University of São Paulo Brazil

Department Medical Oncology Faculty of Medicine and Health Örebro University Örebro Antonios Sweden

Department Medical Oncology Fundación Jimenez Díaz University Hospital Madrid Spain

Department Medical Oncology Institute of Oncology Ljubljana Slovenia

Department Medical Oncology Oncology Institute of Vojvodina University of Novi Sad Serbia

Department Medical Oncology Rooshana Cancer Center Tehran Iran

Department Medical Oncology The Christie NHS Foundation Trust Manchester UK

Department Medical Oncology University Hospital of Ioannina Ioannina Greece

Department of Medical Oncology and Hematology Wilhelminenspital Vienna Austria

Department of Medical Oncology University Hospital of Antwerp Antwerp Belgium

Department of Oncology and Radiotherapy Maria Skłodowska Curie National Research Institute of Oncology Warsaw Poland

Department of Oncology University Hospital Centre Zagreb School of Medicine University of Zagreb Zagreb Croatia

Department of Radiotherapy Specialized Hospital for Active Treatment in Oncology Plovdivsko pole Sofia Bulgaria

Department Oncology and Radiotherapy Charles University Hradec Králové Prague Czech Republic

Department Radiation Oncology Institute of Oncology Ljubljana Slovenia

Department Radiation Oncology National Cancer Center Cancer Hospital Chinese Academy of Medical Sciences Peking Union Medical College Beijing China

Department Radiation Oncology Royal Medical Service Amman Jordan

Department Radiation Oncology University Hospital LMU Munich Germany

Department Radiation Oncology University Hospital of Heraklion Crete Greece

ECPC Partneships and Communication Officer Belgium

ECPC President Belgium

Gastroenterology Acting CEO Shaukat Khanum Memorial Cancer Hospital and Research Centre Lahore and Peshawar Pakistan

Matsudo City General Hospital Chiba Japan

Medical Oncology Auckland Regional Cancer and Blood Service Auckland New Zealand

Medical Oncology Instituto Alexander Fleming in Buenos Aires Buenos Aires Argentina

Medical Oncology Regional Institute of Gastroenterology and Hepatology Prof Dr O Fodor Cluj Napoca Romania

Murmansk Branch of All Russian Association of Cancer Patients Zdravstvuy NGO Center of Initiatives Support Murmansk Russia

National Institute of Oncology Semmelweis University Budapest Hungary

PACMeR Evidence Based Medicine Athens Greece

Radiation Oncology Department Europe Hospitals Brussels Belgium

Radiation Therapy Unit University Hospital Center Mother Teresa Tirana Albania

Radioterapia Oncologica Fondazione Policlinico A Gemelli IRCCS Rome Italy

Service de Haematologie GHT Grand Paris Nord Est G H 1 Le Raincy Montfermeil France GHT Grand Paris Nord Est G H 1 Le Raincy Montfermeil France

Service de Radio Oncologie Neuchâtel Hôpital Network La Chaux de Fonds Switzerland

Service de Radiothérapie Oncologique GHT Grand Paris Nord Est G H 1 Le Raincy Montfermeil France

Service Radio Oncologie Neuchâtel Hôpital Network La Chaux de Fonds Switzerland

The Christie NHS Foundation Trust Manchester UK

The Christie NHS Foundation Trust Manchester UK The Christie\'s Hospital Manchester UK

UCSD Blood and Marrow Transplant Program UCSD Moores Cancer Center La Jolla CA USA

University Hospital for Tumors Sestre Milosrdnice University Hospital Center Zagreb Croatia

Zobrazit více v PubMed

Mauri D., Kamposioras K., Tolia M., Alongi F., Tzachanis D., International Oncology Panel and European Cancer Patient Coalition collaborators Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic. Lancet Oncol. 2020;21(6):759–760. doi: 10.1016/S1470-2045(20)30278-3. PubMed DOI PMC

“A world of languages” Modified with permission from Alberto Lucas Lopez. Available from: https://www.scmp.com/infographics/article/1810040/infographic-world-languages.